# Sepsis Metabolomics

> **NCT01649440** · — · COMPLETED · sponsor: **Chinese PLA General Hospital** · enrollment: 65 (actual)

## Conditions studied

- Normal Control
- SIRS
- Sepsis
- Severe Sepsis
- Death

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01649440
- **Lead sponsor:** Chinese PLA General Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-07
- **Primary completion:** 2012-03
- **Final completion:** 2012-03
- **Target enrollment:** 65 (ACTUAL)
- **Last updated:** 2014-01-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01649440

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01649440, "Sepsis Metabolomics". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01649440. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*